SUDA Enters Licensing Agreement For ZolpiMist in China
Filed with ASX · · 3 pages · English
Arovella Therapeutics Limited on 6ix
Story so far
Earlier from Arovella Therapeutics
- Technology patent application
- Update on HC Berlin Pharma
- Business development update
- SUDA granted Canadian Patent for SUD-002
- Bergen Funding
Later from Arovella Therapeutics
- SUDA presents data on novel technology
- Suspension from official quotation
- Reinstatement to official quotation
- SUDA Update On Discussions with Berlin Pharma
- SUDA Announces Strong Revenue For Westcoast
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics